Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 14, 2014 - Issue 8
Submit an article Journal homepage
1,022
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis

Mark S FreedmanUniversity of Ottawa and the Ottawa Hospital Research Institute, Department of Medicine, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada+1 613 737 8532; +1 613 737 8162; [email protected]
, MSc MD
Pages 1207-1214 | Published online: 26 Jun 2014

Reprints and Permissions

Taylor & Francis does not sell reprints or permissions for this article. Please refer to the 'Licensing' tab on the article menu bar for information on the reuse conditions associated with this license type.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.